Imatinib Mesylate
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
- Title
- Imatinib Mesylate
- Record Date
- 01/01/2024
- Vuga Group
- Imatinib Mesylate
- Change Status
- increased
- Recency Days
- 972.23
- Public Significance Score
- 22.711